Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:THOR

Synthorx (THOR) Stock Price, News & Analysis

Synthorx logo

About Synthorx Stock (NASDAQ:THOR)

Advanced Chart

Key Stats

Today's Range
$67.99
$67.99
50-Day Range
$67.99
$67.99
52-Week Range
$11.05
$71.90
Volume
N/A
Average Volume
474,507 shs
Market Capitalization
$2.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive THOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Synthorx and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

THOR Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
Biosimilar Interleukins Global Market Report 2023
See More Headlines

THOR Stock Analysis - Frequently Asked Questions

Synthorx, Inc. (NASDAQ:THOR) released its earnings results on Tuesday, November, 5th. The medical instruments supplier reported ($0.38) earnings per share for the quarter, beating analysts' consensus estimates of ($0.50) by $0.12.

Synthorx (THOR) raised $100 million in an IPO on Friday, December 7th 2018. The company issued 9,100,000 shares at a price of $10.00-$12.00 per share. Jefferies, Leerink Partners and Evercore ISI acted as the underwriters for the IPO and H.C. Wainwright & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Synthorx investors own include Pfizer (PFE), NVIDIA (NVDA), Gilead Sciences (GILD), Meta Platforms (META), Alibaba Group (BABA), Tesla (TSLA) and Salesforce (CRM).

Company Calendar

Last Earnings
11/05/2019
Today
8/26/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:THOR
CIK
350907
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($6.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$56.61 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-26.09%
Return on Assets
-24.62%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
18.87
Quick Ratio
18.87

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.72 per share
Price / Book
10.12

Miscellaneous

Outstanding Shares
32,338,000
Free Float
N/A
Market Cap
$2.20 billion
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:THOR) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners